Search for Clinical Trial Results

Rhabdomyosarcoma Embryonal - 11 Studies Found
Status | Study |
Recruiting |
Study Name: Insulin-like Growth Factor 1 Receptor (IGF-1R) Antibody AMG479 (Ganitumab) in Combination With the Src Family Kinase (SFK) Inhibitor Dasatinib in People With Embryonal and Alveolar Rhabdomyosarcoma Condition:
|
Recruiting |
Study Name: Vincristine, Dactinomycin, and Cyclophosphamide in Treating Patients With Embryonal Rhabdomyosarcoma Condition: Sarcoma Date: 2005-10-25 Interventions:
|
Recruiting |
Study Name: Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Embryonal Rhabdomyosarcoma Condition: Sarcoma Date: 2005-10-25 Interventions:
|
Active, not recruiting |
Study Name: Therapy to Treat Ewing's Sarcoma, Rhabdomyosarcoma or Neuroblastoma Condition:
|
Suspended |
Study Name: Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma Condition:
|
Active, not recruiting |
Study Name: Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma Condition:
|
Completed |
Study Name: Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma Condition:
Interventions: |
Completed |
Study Name: Biomarkers in Patients With Advanced Rhabdomyosarcoma Condition:
Interventions: Other: Laboratory Biomarker Analysis Correlative studies |
Completed |
Study Name: Collecting Tumor Samples From Patients With Gynecological Tumors Condition:
|